Chenlu Xiao
Overview
Explore the profile of Chenlu Xiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo J, Xiao C, Tian W, Lv L, Hu L, Ni L, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Nov;
43(2):249-257.
PMID: 38030860
Purpose: The objective of this multicenter study was to compare the diagnostic performance of lateral flow assay (LFA) and enzyme-linked immunosorbent assay (ELISA) to detect the Dynamiker Aspergillus Galactomannan levels...
2.
Lin H, Guo J, Li Y, Xiao C, Hu L, Chen H, et al.
Med Mycol
. 2023 Aug;
61(9).
PMID: 37580143
Aspergillus species is a widespread environmental mould that can cause aspergillosis. The purpose of this study was to investigate the antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates...
3.
Hua L, Yang Z, Xiao C
Clin Lab
. 2023 Jul;
69(7).
PMID: 37436372
Background: Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a powerful technique for the identification of microorganisms. The technique normally requires a sample preparation procedure before instrumental analysis,...
4.
Xiao C, Li X, Huang L, Cao H, Han L, Ni Y, et al.
Front Cell Infect Microbiol
. 2023 May;
13:1118122.
PMID: 37143741
Introduction: Polymyxin-resistant poses a significant threat to public health globally, but its prevalence and genomic diversity within a sole hospital is less well known. In this study, the prevalence of...
5.
Xiao C, Qiao D, Xiong L, Tian W, Wang D, Deng S, et al.
Infect Drug Resist
. 2022 Dec;
15:7249-7257.
PMID: 36533254
Background: spp. infection in immunocompromised patients results in increasing morbidity and mortality. This study investigated clinical and microbiological characteristics of aspergillosis in a Chinese tertiary teaching hospital. Methods: A total...
6.
Xiao C, Zhu Y, Yang Z, Shi D, Ni Y, Hua L, et al.
Antibiotics (Basel)
. 2022 Jun;
11(6).
PMID: 35740205
Polymyxin-resistant is a major threat to public health globally. We investigated the prevalence of polymyxin-resistant in a Chinese teaching hospital and determined the genetic and drug-resistant phenotypes of the resistant...
7.
Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, et al.
Front Med
. 2022 Mar;
16(2):263-275.
PMID: 35258762
Emerging evidence indicates that the gut microbiome contributes to the host immune response to infectious diseases. Here, to explore the role of the gut microbiome in the host immune responses...
8.
Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, et al.
Cell Discov
. 2021 Jun;
7(1):42.
PMID: 34103487
The pathophysiology of coronavirus disease 19 (COVID-19) involves a multitude of host responses, yet how they unfold during the course of disease progression remains unclear. Here, through integrative analysis of...
9.
Tsang C, Tang J, Ye H, Xing F, Lo S, Xiao C, et al.
Mycoses
. 2020 Sep;
63(12):1283-1298.
PMID: 32918365
Background: The number of patients infected with Aspergillus rose dramatically in recent years. However, studies on the clinical spectrum and antifungal susceptibilities of non-classical (non-fumigatus, non-flavus, non-niger and non-terreus) pathogenic...
10.
Chan J, Lau S, Wong S, To K, So S, Leung S, et al.
Emerg Microbes Infect
. 2016 Apr;
5:e37.
PMID: 27094904
In recent years, infections caused by Aspergillus sp. have become an emerging focus of clinical microbiology and infectious disease, as the number of patients infected with Aspergillus sp. has increased...